Zhang et al. [36] performed interferon-γ (IFN-γ) treatment in patients with synovial sarcoma and MLPS and demonstrated that IFN-γ treatment can increase expression level of HLA class I and PD-L1. This evidence concerns the gene CD274 and synovial sarcoma.